Oneness Biotech Future Growth
Future criteria checks 2/6
Oneness Biotech is forecast to grow earnings and revenue by 46.9% and 47.5% per annum respectively. EPS is expected to grow by 47.4% per annum. Return on equity is forecast to be -6.8% in 3 years.
Key information
46.9%
Earnings growth rate
47.4%
EPS growth rate
| Pharmaceuticals earnings growth | 36.4% |
| Revenue growth rate | 47.5% |
| Future return on equity | -6.8% |
| Analyst coverage | Low |
| Last updated | 07 Dec 2023 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 309 | -890 | N/A | -1,542 | 1 |
| 12/31/2024 | 1,345 | -82 | -315 | 1,041 | 2 |
| 12/31/2023 | 87 | -1,313 | -513 | -422 | N/A |
| 9/30/2023 | 76 | -1,469 | -880 | -772 | N/A |
| 6/30/2023 | 71 | -967 | -909 | -823 | N/A |
| 3/31/2023 | 1,068 | -293 | -1,028 | -944 | N/A |
| 12/31/2022 | 1,066 | 360 | -970 | -881 | N/A |
| 9/30/2022 | 1,069 | 1,131 | -724 | -648 | N/A |
| 6/30/2022 | 1,079 | 679 | -706 | -605 | N/A |
| 3/31/2022 | 75 | -132 | -700 | -580 | N/A |
| 12/31/2021 | 66 | -403 | -389 | -289 | N/A |
| 9/30/2021 | 52 | -1,099 | -287 | -146 | N/A |
| 6/30/2021 | 30 | -901 | -217 | -83 | N/A |
| 3/31/2021 | 49 | 64 | 160 | 314 | N/A |
| 12/31/2020 | 42 | -242 | 5 | 158 | N/A |
| 9/30/2020 | 39 | 156 | -46 | 52 | N/A |
| 6/30/2020 | 42 | 75 | -12 | 72 | N/A |
| 3/31/2020 | 13 | -481 | -229 | -186 | N/A |
| 12/31/2019 | 13 | -322 | -261 | -213 | N/A |
| 9/30/2019 | 16 | -202 | -88 | -10 | N/A |
| 6/30/2019 | 15 | -255 | -94 | -2 | N/A |
| 3/31/2019 | 16 | -209 | -114 | 10 | N/A |
| 12/31/2018 | 19 | -235 | -172 | -5 | N/A |
| 9/30/2018 | 15 | -230 | -338 | -135 | N/A |
| 6/30/2018 | 12 | -151 | -382 | -140 | N/A |
| 3/31/2018 | 10 | -171 | -437 | -157 | N/A |
| 12/31/2017 | 3 | -155 | -478 | -165 | N/A |
| 9/30/2017 | 3 | -149 | N/A | -176 | N/A |
| 6/30/2017 | 4 | -34 | N/A | -148 | N/A |
| 3/31/2017 | 5 | -21 | N/A | -128 | N/A |
| 12/31/2016 | 6 | -14 | N/A | -109 | N/A |
| 9/30/2016 | 6 | -5 | N/A | -96 | N/A |
| 6/30/2016 | 5 | -106 | N/A | -110 | N/A |
| 3/31/2016 | 9 | -103 | N/A | -139 | N/A |
| 12/31/2015 | 8 | -93 | N/A | -142 | N/A |
| 9/30/2015 | 7 | -27 | N/A | -120 | N/A |
| 6/30/2015 | 8 | 172 | N/A | -145 | N/A |
| 3/31/2015 | 5 | 195 | N/A | -157 | N/A |
| 12/31/2014 | 5 | 200 | N/A | -151 | N/A |
| 9/30/2014 | 5 | 118 | N/A | -167 | N/A |
| 6/30/2014 | 4 | 116 | N/A | -130 | N/A |
| 3/31/2014 | 4 | 236 | N/A | -93 | N/A |
| 12/31/2013 | 5 | 276 | N/A | -89 | N/A |
| 9/30/2013 | 7 | 330 | N/A | -76 | N/A |
| 6/30/2013 | 9 | 111 | N/A | -77 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4743 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 4743 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 4743 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 4743's revenue (47.5% per year) is forecast to grow faster than the TW market (10.6% per year).
High Growth Revenue: 4743's revenue (47.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4743 is forecast to be unprofitable in 3 years.